## Abstract Polymorphisms in the TOR1A/TOR1B region have been implicated as being associated with primary focal and segmental dystonia. In a cohort of subjects with either focal or segmental dystonia affecting the face, larynx, neck, or arm, we report a strong association of a single nucleotide pol
Inherited myoclonus-dystonia and epilepsy: Further evidence of an association?
β Scribed by Sean O'Riordan; Laurie J. Ozelius; Patricia De Carvalho Aguiar; Michael Hutchinson; Mary King; Tim Lynch
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 66 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Epilepsy and electroencephalogram (EEG) abnormalities have been considered exclusion criteria for the clinical diagnosis of myoclonusβdystonia (MβD). We report on the second MβD family in which several clinically affected Ο΅βsarcoglycan gene (SGCE) mutation carriers have seizures in addition to myoclonus and dystonia, adding to the evidence that epilepsy and EEG abnormalities may form part of the phenotypic spectrum of the condition. A nonsense mutation in exon 3 (289CβT) of SGCE resulting in the insertion of a premature stop codon (R97X) was detected in affected members of this family. Β© 2004 Movement Disorder Society
π SIMILAR VOLUMES
Paraoxonase1 (PON1) is an arylesterase mainly expressed in the liver that hydrolyzes organophosphates such as pesticides, reported risk factors for Parkinson's disease (PD), and other neurotoxins. A Leu-Met 54 polymorphism in the gene for PON1-affecting enzyme activity was recently shown, employing